Northpointe Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-65,540
Closed -$1.76M 241
2013
Q2
$1.76M Buy
+65,540
New +$1.76M 0.2% 114